Remedy Technologies develops AI agents that automate pharmacy workflows, manage prescription refills, and handle insurance and billing.
Remedy Technologies has raised $500K in total funding. The most recent round was Pre-Seed. The last funding was announced in September 2025.
Remedy Technologies's investors include Y Combinator.
Remedy Technologies is headquartered in Austin, United States.
Remedy Technologies develops AI agents that automate pharmacy workflows, manage prescription refills, and handle insurance and billing.
Remedy Technologies is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Remedy Technologies — Funding & Investors." VCBacked, September 5, 2025, https://www.vcbacked.co/company/remedy-technologies. Accessed September 29, 2026.
VCBacked. (2025). Remedy Technologies — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/remedy-technologies
{{cite web |title=Remedy Technologies — Funding & Investors |url=https://www.vcbacked.co/company/remedy-technologies |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated